Losartan for the Nephropathy of Sickle Cell Anemia: A Phase ‐2, Multi‐Center Trial

This study forms the basis for a phase‐3, randomized, placebo‐controlled trial of losartan for the nephropathy of SCA. This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - June 7, 2017 Category: Hematology Authors: Charles T. Quinn, Santosh L. Saraf, Victor R. Gordeuk, Courtney D. Fitzhugh, Susan E. Creary, Prasad Bodas, Alex George, Ashok B. Raj, Alecia C. Nero, Catherine E. Terrell, Lisa McCord, Adam Lane, Hans C. Ackerman, Yu Yang, Omar Niss, Michael D. Taylor, P Tags: Research Article Source Type: research